• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗新生血管治疗方案与治疗-观察方案治疗年龄相关性黄斑变性脉络膜新生血管:系统评价和荟萃分析。

STRICT PRO RE NATA VERSUS TREAT-AND-EXTEND REGIMENS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.

机构信息

Department of Ophthalmology, Shin-Kong Wu Ho-Su Memorial Hospital.

Department of Public Health, College of Medicine, Taipei Medical University.

出版信息

Retina. 2023 Mar 1;43(3):420-432. doi: 10.1097/IAE.0000000000003690.

DOI:10.1097/IAE.0000000000003690
PMID:36669130
Abstract

PURPOSE

To compare the visual and anatomical outcomes between strict pro re nata (strict PRN) and treat-and-extend (T&E) anti-vascular endothelial growth factor (anti-VEGF) regimens for neovascular age-related macular degeneration (nAMD).

METHODS

A meta-analysis of 1-year and 2-year changes between strict PRN and T&E anti-VEGF regimens were conducted in both randomized controlled trials (RCTs) and real-world studies (RWSs). The best-corrected visual acuity (BCVA), central retinal thickness (CRT), and weighted mean numbers of visits and injections were evaluated.

RESULTS

A total of 19 RCTs and 23 RWSs (2,530 eyes in strict PRN and 4,399 eyes in T&E) were included. Mean BCVA change in strict PRN group in both 1-year and 2-year (5.95 and 5.78, respectively) was noninferior to the T&E group (7.85 and 5.96, respectively). Mean CRT changes were also similar in both strict PRN and T&E groups. Mean number of visits were significantly more in the strict PRN group, whereas mean number of injections was significantly more in the T&E group.

CONCLUSION

The strict PRN regimen demonstrates a noninferior BCVA improvement to the T&E regimen, achieving fewer injections, and may be both economically and medically beneficial. Both selections should be provided to patients with an overall consideration.

摘要

目的

比较严格按需(strict pro re nata,strict PRN)与治疗-延长(treat-and-extend,T&E)抗血管内皮生长因子(anti-vascular endothelial growth factor,anti-VEGF)方案治疗新生血管性年龄相关性黄斑变性(neovascular age-related macular degeneration,nAMD)的视力和解剖学结局。

方法

对严格 PRN 和 T&E 抗 VEGF 方案的 1 年和 2 年随机对照试验(randomized controlled trials,RCT)和真实世界研究(real-world studies,RWS)的变化进行了荟萃分析。评估了最佳矫正视力(best-corrected visual acuity,BCVA)、中心视网膜厚度(central retinal thickness,CRT)以及加权平均就诊和注射次数。

结果

共纳入 19 项 RCT 和 23 项 RWS(严格 PRN 组 2530 只眼,T&E 组 4399 只眼)。严格 PRN 组在 1 年和 2 年的平均 BCVA 变化分别为 5.95 和 5.78,均不劣于 T&E 组(分别为 7.85 和 5.96)。严格 PRN 和 T&E 组的 CRT 变化也相似。严格 PRN 组的平均就诊次数明显更多,而 T&E 组的平均注射次数明显更多。

结论

严格 PRN 方案显示出与 T&E 方案相似的 BCVA 改善,注射次数更少,在经济和医学上可能都具有优势。应该综合考虑为患者提供这两种选择。

相似文献

1
STRICT PRO RE NATA VERSUS TREAT-AND-EXTEND REGIMENS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.抗新生血管治疗方案与治疗-观察方案治疗年龄相关性黄斑变性脉络膜新生血管:系统评价和荟萃分析。
Retina. 2023 Mar 1;43(3):420-432. doi: 10.1097/IAE.0000000000003690.
2
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study.雷珠单抗治疗并延长给药方案与按需给药方案治疗新生血管性年龄相关性黄斑变性的比较:一项为期12个月的对照研究
Acta Ophthalmol. 2017 Feb;95(1):e67-e72. doi: 10.1111/aos.13031. Epub 2016 Mar 24.
3
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.血管内皮生长因子抑制剂治疗新生血管性年龄相关性黄斑变性的眼内黄斑萎缩发生率和进展:MANEX 研究四年结果。
Ophthalmology. 2020 Dec;127(12):1663-1673. doi: 10.1016/j.ophtha.2020.06.019. Epub 2020 Jun 13.
4
Switching from pro re nata to treat-and-extend regimen improves visual acuity in patients with neovascular age-related macular degeneration.从按需治疗方案转换为治疗并延长方案可提高新生血管性年龄相关性黄斑变性患者的视力。
Acta Ophthalmol. 2017 Nov;95(7):678-682. doi: 10.1111/aos.13356. Epub 2017 Jan 31.
5
Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis.抗血管内皮生长因子药物玻璃体腔内注射治疗新生血管性年龄相关性黄斑变性的按需治疗策略:一项荟萃分析。
Eye (Lond). 2023 Oct;37(14):2855-2863. doi: 10.1038/s41433-023-02439-6. Epub 2023 Mar 1.
6
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens.COVID-19 对不同治疗方案的新生血管性年龄相关性黄斑变性患者稳定性的影响。
Adv Ther. 2022 Apr;39(4):1568-1581. doi: 10.1007/s12325-021-01993-3. Epub 2021 Nov 24.
7
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study.每月 2 次、按需和治疗-扩展治疗方案治疗初治新生血管性年龄相关性黄斑变性患者:一项随机研究的 12 个月结果。
Acta Ophthalmol. 2020 Nov;98(7):e820-e829. doi: 10.1111/aos.14399. Epub 2020 Mar 19.
8
To investigate treat and extend versus pro re nata regimen in neovascular age-related macular degeneration: results from the IDEM study.探讨治疗和延长与 pro re nata 方案在新生血管性年龄相关性黄斑变性中的应用:来自 IDEM 研究的结果。
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2149-2156. doi: 10.1007/s00417-021-05543-z. Epub 2022 Jan 12.
9
Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.雷珠单抗治疗初诊新生血管性年龄相关性黄斑变性的策略比较
J Ocul Pharmacol Ther. 2017 Dec;33(10):773-778. doi: 10.1089/jop.2017.0006. Epub 2017 Sep 27.
10
Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study.雷珠单抗和阿柏西普治疗及延长给药方案与按需给药方案治疗新生血管性年龄相关性黄斑变性的比较研究
Graefes Arch Clin Exp Ophthalmol. 2019 Sep;257(9):1889-1895. doi: 10.1007/s00417-019-04404-0. Epub 2019 Jun 29.

引用本文的文献

1
Long-term remission and incidence of recurrence of neovascularization in intravitreal injection treated exudative age-related macular degeneration.玻璃体内注射治疗渗出性年龄相关性黄斑变性的长期缓解及新生血管复发率
Graefes Arch Clin Exp Ophthalmol. 2025 Jul 3. doi: 10.1007/s00417-025-06885-8.
2
Expanding Application of Optical Coherence Tomography Beyond the Clinic: A Narrative Review.光学相干断层扫描在临床之外的扩展应用:一项叙述性综述
Diagnostics (Basel). 2025 Apr 29;15(9):1140. doi: 10.3390/diagnostics15091140.
3
Session-by-Session Prediction of Anti-Endothelial Growth Factor Injection Needs in Neovascular Age-Related Macular Degeneration Using Optical-Coherence-Tomography-Derived Features and Machine Learning.
利用光学相干断层扫描衍生特征和机器学习逐次预测新生血管性年龄相关性黄斑变性中抗血管内皮生长因子注射需求
Diagnostics (Basel). 2024 Nov 21;14(23):2609. doi: 10.3390/diagnostics14232609.
4
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.家庭光学相干断层扫描(OCT)数据在新生血管性年龄相关性黄斑变性管理中的临床应用
J Vitreoretin Dis. 2024 Dec 7:24741264241302858. doi: 10.1177/24741264241302858.